OVARIAN CANCER BY FIGO STAGE

Clinical trials for OVARIAN CANCER BY FIGO STAGE explained in plain language.

Never miss a new study

Get alerted when new OVARIAN CANCER BY FIGO STAGE trials appear

Sign up with your email to follow new studies for OVARIAN CANCER BY FIGO STAGE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New hope for ovarian cancer: drug cocktail shows promise in early trial

Disease control Ongoing

This study tests a combination of four drugs (oregovomab, bevacizumab, paclitaxel, carboplatin) in adults with recurrent ovarian cancer that has a specific genetic profile (BRCA-normal). The goal is to see if the combo is safe and can shrink tumors or slow cancer growth. About 54…

Matched conditions: OVARIAN CANCER BY FIGO STAGE

Phase: PHASE1, PHASE2 • Sponsor: CanariaBio Inc. • Aim: Disease control

Last updated Apr 26, 2026 19:38 UTC

OVARIAN CANCER BY FIGO STAGE

Get alerted when new OVARIAN CANCER BY FIGO STAGE trials appear

New hope for ovarian cancer: drug cocktail shows promise in early trial